drugset / Trial / NCT03062956
A Single Ascending Dose Study Assessing the Safety, Tolerability, PK and PD of MYK-491
RandomizedSequentialQuadruple-blindTreatment
Summary
Up to 72 healthy volunteers will be given a single dose of MYK-491 or placebo and be monitored for safety and tolerability over a 7 day period.
Timeline
- Start
- 2017-01-16
- Primary completion
- 2017-11-28
- Completion
- 2017-11-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Danicamtiv | Small molecule | — | Oral |